![GeneVentiv Invited to Present in Labcorp’s Symposium at the 26th Annual Meeting of the American Society of Cell and Gene Therapy](https://www.geneventiv.com/wp-content/uploads/2023/04/ASGCT-26th-Annual-Meeting.jpg)
![GeneVentiv Invited to Present in Labcorp’s Symposium at the 26th Annual Meeting of the American Society of Cell and Gene Therapy](https://www.geneventiv.com/wp-content/uploads/2023/04/ASGCT-26th-Annual-Meeting.jpg)
Recent Posts
- GeneVentiv Welcomes New Scientific Advisory Board Member, Sylvia Fong
- GeneVentiv Therapeutics Awarded $2.5 Million SBIR Grant to Advance Gene Therapy for All Hemophilias, with or without Inhibitors
- New partners to develop universal gene therapy for hemophilia
- ReciBioPharm and GeneVentiv Therapeutics partner to advance first AAV-based gene therapy for haemophilia patients with inhibitors
- GeneVentiv to Attend BIO CEO & Investor Conference
Recent Comments